Press Releases

Mar 08, 2021

Meridian Launches its New Air-Dryable Mix for Crude Blood Samples

read more

Mar 04, 2021

Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference

read more

Feb 23, 2021

Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal

read more

Feb 23, 2021

Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission

read more

Feb 16, 2021

Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission

read more

Feb 05, 2021

Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance

read more

Feb 03, 2021

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown

read more

Feb 02, 2021

Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays

read more

Jan 13, 2021

Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021

read more

Jan 07, 2021

Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results

read more

Jan 06, 2021

Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference

read more

Dec 16, 2020

Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2

read more

Dec 08, 2020

Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

read more

Dec 03, 2020

Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers

read more

Nov 23, 2020

Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference

read more

Nov 16, 2020

Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum

read more

Nov 13, 2020

Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance

read more

Oct 20, 2020

Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020

read more

Oct 07, 2020

Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics

read more

Sep 14, 2020

Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples

read more